SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-011527
Filing Date
2024-03-27
Accepted
2024-03-27 16:45:35
Documents
15
Period of Report
2024-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50661
2 ex99-01.htm EX-99.01 78798
3 ex99-01_001.jpg GRAPHIC 2435
  Complete submission text file 0001493152-24-011527.txt   318484

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pali-20240327.xsd EX-101.SCH 3024
5 XBRL LABEL FILE pali-20240327_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE pali-20240327_pre.xml EX-101.PRE 22365
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3662
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 24791484
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)